COVID-19 Clinical Trials & Research

Paving the way for progress, clinical trials are how we advance healthcare and ultimately, save more lives. Tallahassee Memorial HealthCare is proud to offer a national network of clinical trials for COVID-19 research in the Big Bend.

COVID-19 Convalescent Plasma (CCP) Collection & Treatment

During this challenging fight against coronavirus (COVID-19), the United States Government is supporting a national Expanded Access Program to collect and provide a convalescent plasma treatment to patients in need. The plasma recovered from COVID-19 patients contains antibodies that may be important to the future of fighting this disease.

Tallahassee Memorial HealthCare (TMH) is collaborating with academic, government and industry partners to serve as a partner in the Mayo expanded access protocol program. This is a resource that will potentially benefit all patients in our region, not just those at TMH. 

Who is eligible for CCP Collection (donation)?

In addition to the usual criteria for blood donation, eligible patients must have:

  • Documented COVID-19 positive test from an FDA-approved laboratory. This includes a positive diagnostic test at the time of illness OR a positive serological test for SARS-CoV-2 antibodies after recovery.
  • Documented recovery from COVID-19 (14 days since last symptom with a negative COVID-19 FDA approved test, or 28 days without a follow-up test).
  • Certification of their OneBlood health history form, by a physician.

Who is eligible for CCP Treatment?

Patients with COVID-19 may improve faster if they receive plasma from those who have recovered from COVID-19, because it may have the ability to fight the virus that causes COVID-19. We are able to offer this investigational therapy to TMH’s severe COVID-19 in-patient population.

How does it work?

TMH is a participating site in the Mayo clinical expanded access protocol. Our local blood bank, OneBlood, is working to accept donations. Patients can sign up online at to donate. Details on this treatment and specifications about eligibility criteria can be found on the OneBlood or FDA website.


COVID-19 HERO Registry

Recently launched, the Healthcare Worker Exposure Response & Outcomes (HERO) Registry invites US healthcare workers to share their clinical and life experiences to help researchers understand the perspectives and problems faced by those on the frontlines of the COVID-19 pandemic. Tallahassee Memorial HealthCare (TMH) is one of the many healthcare organizations across the country participating in the HERO Registry.

How does it work?

You can use a work or personal email account to register online. The HERO registry is hosted on a secure, Google cloud account. Once on the registry website, you will click the “Join the Registry” green button to get started. Follow the prompts provided to setup a HERO registry account. After joining you will receive surveys, opportunities to participate in future studies and learnings from the HERO research community.

Who is eligible?

The HERO Registry is open to all healthcare workers, defined as anyone who works in a setting where people receive healthcare. This includes nurses, therapists, physicians, emergency responders, food service workers, environmental service workers, interpreters, transporters and others.

To register, please visit

For more information, please contact Kristin Herman at Kristin.Herman@TMH.ORG.